Janssen-Cilag (Johnson & Johnson) is recalling its [transdermal] fentanyl patch, Ionsys, 40μg/dose from the market in 14 countries, because some patches have been found to self-activate, which may potentially cause an overdose.
The UK's regulatory authority, theMHRA, notes that it is a class 1 drug alert, with the device being removed from...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?